Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Rein
- | Specialty :
- Thérapies Ciblées
- Chimiothérapie
Extract
Phase 3b, randomized, open-label study of bevacizumab + temsirolimus vs. bevacizumab + interferon-alfa as first-line treatment in subjects with advanced renal cell carcinoma.
Scientific Abstract
en cours d'intégration;